Biodexa Pharmaceuticals plc balance sheet

At the end of fiscal 2023, Biodexa Pharmaceuticals plc had total assets of $13.4m, total liabilities of $7.5m and shareholders' equity of $6.0m. It held $7.6m in cash against $375,919 of debt: net cash of $7.2m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Biodexa Pharmaceuticals plc: balance sheet, annual
Fiscal year	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023
Cash and equivalents	24	22	18	3	15	10	14	3	8
Receivables	4	3	4	2	1	1	1	1	1
Inventory	1	1	1	—	—	—	—	—	—
Total current assets	30	28	25	7	18	13	16	6	9
Goodwill	—	—	18	3	3	0	—	—	—
Total assets	94	70	67	26	41	13	17	7	13
Total current liabilities	13	12	11	3	8	4	2	2	7
Long-term debt	2	2	8	1	8	0	1	1	0
Total debt	2	2	8	1	8	0	1	1	0
Total liabilities	25	14	20	4	15	4	3	3	7
Shareholders' equity	69	56	47	22	26	9	14	4	6
Net debt (negative = net cash)	−22	−20	−9	−2	−7	−10	−13	−3	−7

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Biodexa Pharmaceuticals plc's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Biodexa Pharmaceuticals plc.